[HTML][HTML] Long-term treatment outcomes in patients with multidrug-resistant tuberculosis

C Maier, D Chesov, D Schaub, B Kalsdorf… - Clinical Microbiology …, 2023 - Elsevier
Objectives To describe long-term treatment outcomes in patients with multi-drug-
resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and validate established outcome …

Long-term treatment outcomes in multidrug-resistant tuberculosis.

C Maier, D Chesov, D Schaub, B Kalsdorf… - … and Infection: the …, 2023 - europepmc.org
Objectives We describe long-term treatment outcomes in patients with multidrug-
resistant/rifampicin-resistant (MDR/RR)-tuberculosis (TB) and validate established MDR/RR …

[HTML][HTML] Long-term treatment outcomes in patients with multidrug-resistant tuberculosis

C Maier, D Chesov, D Schaub… - Clinical …, 2023 - clinicalmicrobiologyandinfection …
Objectives To describe long-term treatment outcomes in patients with multi-drug-
resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and validate established outcome …

Long-term treatment outcomes in patients with multidrug-resistant tuberculosis.

C Maier, D Chesov, D Schaub, B Kalsdorf, S Andres… - 2023 - cabidigitallibrary.org
Objectives: To describe long-term treatment outcomes in patients with multi-drug-
resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and validate established outcome …

Long-term treatment outcomes in patients with multidrug-resistant tuberculosis

C Maier, D Chesov, D Schaub, B Kalsdorf… - Clinical Microbiology …, 2023 - ibn.idsi.md
Objectives: To describe long-term treatment outcomes in patients with multi-drug-
resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and validate established outcome …

Long-term treatment outcomes in patients with multidrug-resistant tuberculosis

C Maier, D Chesov, D Schaub… - … and infection: the …, 2023 - pubmed.ncbi.nlm.nih.gov
Objectives To describe long-term treatment outcomes in patients with multi-drug-
resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) and validate established outcome …